Trading status Status de
  • Prices realtime
    • Indizes
      • Germany 40
      • MID Germany 50
      • TEC Germany 30
      • USA 30
      • EUROPE 50
      • TEC USA 100
    • Shares
    • ETFs & FUNDS
    • Bonds
    • Crypto
  • Screen markets
    • Stock screener
    • Certifcate Screener
    • ETF Screener
    • Fund Screener
    • Bond screener
  • Trading ideas
    • risk indices
      • risk indices
      • EU Intraday
      • EU Long Term
      • US Intraday
      • US Longterm
    • Newsletter
    • Blog
    • Newsletter
    • Watchlist
    • Support
  • Trading
    • Trading Calendar
    • New on gettex
      • New listings stocks
      • New listings bonds
      • New intraday certificates
    • Extended trading hours
    • Listing on demand
    • Announcements
    • Quality Reports
    • Delayed Data
    • Regulations
    • Become a Trade Participant
    • Cancellations
  • About Gettex
    • FAQs
    • Press
    • Partners
    • Committees
    • Career
    • Service & Contact
  • Why gettex

News overview

  • «
  • ‹
  • …
  • 10016
  • 10017
  • 10018
  • …
  • ›
  • »

2026-04-15

ReconAfrica Provides Operational Update and Reports 2025 Year-End Results

2026-04-15

Canadian Copper secures up to $70M to develop New Brunswick complex

2026-04-15

Are Westpac and Bank of Queensland shares a buy, hold or sell?

2026-04-15

361 Degrees Main Brand 1Q26 Offline Retail Sales Up 10% YoY

2026-04-15

CStone Pharmaceuticals Places Shares at Nearly 7% Discount, Net Proceeds HKD1.053B

2026-04-15

LAEKNA Phase III Breast Cancer Trial Meets Primary Endpoint with Significant PFS Improvement

2026-04-15

Why are Boss Energy shares crashing 14% today?

2026-04-15

‘Meaningful reduction’: Avita achieves positive Cohealyx grafting study interim results

2026-04-15

Compared to Estimates, Equity Bancshares (EQBK) Q1 Earnings: A Look at Key Metrics

2026-04-15

One Year On: Is Intact Financial Still Worth Buying for its Dividend?

2026-04-15

Alligator Energy Reports Strong Uranium Grades in Early Samphire Field Recovery Trial Results

2026-04-15

Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products

  • «
  • ‹
  • …
  • 10016
  • 10017
  • 10018
  • …
  • ›
  • »

Preset online depot

Favorites: Zertifikate-Finder FAQs Newsletter
Realtimeprices 11/Sep/2026 15:08:20
Tradingtime Mo-Fr: 7:30-23 h
Certificates 8:00-22 h
  • Imprint
  • Legal notice
  • Data protection
  • Contact
  • Cookies